Overcoming opioid addiction is possible, and the most effective path combines medication with behavioral support. People who use medication-based treatment reduce their risk of fatal overdose by 34% to 38% compared to no treatment at all. Abstinence-only approaches, by contrast, actually increase the risk of death by over 77% compared to doing nothing. That finding, from Yale School of Public Health, makes one thing clear: medication isn’t a crutch. It’s the foundation of successful recovery.
What Happens in Your Brain During Addiction
Opioids work by binding to receptors in your brain that control pain and pleasure. With repeated use, your brain adapts. It reduces its own natural production of feel-good chemicals and becomes less responsive to the opioids themselves, which is why you need more over time to get the same effect. This process, called desensitization, changes how your brain’s receptors function at a cellular level.
Research in the Journal of Neuroscience shows that after chronic opioid use, the receptors lose their ability to recover and recycle normally. In untreated brain tissue, receptors recovered about 71% of their function within 45 minutes. After chronic morphine exposure, that recovery dropped to just 42%. Your brain can heal, but the process is slow and uneven, which is why withdrawal feels so intense and why cravings can persist for months after you stop using.
What Withdrawal Actually Feels Like
Withdrawal is the first physical barrier, and knowing what to expect makes it less frightening. For fast-acting opioids like heroin or oxycodone, acute withdrawal typically lasts four to five days. For longer-acting opioids like methadone, it can stretch to a week or more. Symptoms usually begin 8 to 24 hours after your last dose.
The experience hits multiple systems at once. You can expect muscle and joint aches, stomach cramps, nausea, vomiting, or diarrhea. Your pulse rises. You sweat, get goosebumps, and your eyes water. Sleep becomes nearly impossible because of restlessness and anxiety. Yawning, oddly enough, becomes constant. These symptoms peak around days two and three, then gradually ease.
What many people don’t anticipate is the second phase. After the acute symptoms pass, a longer stretch of low-grade discomfort sets in: disrupted sleep, irritability, difficulty concentrating, and lingering cravings. This can last weeks to months. It’s not dangerous, but it’s the phase where relapse risk is highest because people assume they should feel normal by then and interpret ongoing discomfort as a sign that recovery isn’t working.
Medications That Work
Three FDA-approved medications treat opioid use disorder, and they work in fundamentally different ways. The choice depends on where you are in recovery, your treatment history, and what’s accessible to you.
Buprenorphine
Buprenorphine partially activates the same receptors that opioids target, which reduces cravings and withdrawal without producing a significant high. One study found that 60% of participants stayed opioid-free on buprenorphine, compared to just 20% with no treatment or a placebo. It comes as a tablet that dissolves under the tongue, a film placed against the cheek, a skin patch, or an injection. Since 2023, any licensed prescriber can offer buprenorphine without a special waiver, which has dramatically expanded access. You can take it at home, pick it up at a pharmacy, and maintain a normal daily routine.
Methadone
Methadone fully activates opioid receptors at a controlled, steady level. It eliminates withdrawal, blocks cravings, and prevents other opioids from producing euphoria. It keeps people in treatment longer than any other option, with opioid-free rates also reaching around 60%. The tradeoff is logistics: methadone for addiction must be dispensed through specialized clinics, which often means daily visits, especially early in treatment. Updated 2024 federal regulations have loosened some of these restrictions, allowing more take-home doses, but it still requires more structure than buprenorphine.
Naltrexone
Naltrexone takes the opposite approach. Instead of activating opioid receptors, it blocks them entirely. If you use opioids while on naltrexone, you won’t feel any effect. The extended-release injection, given once a month, showed strong retention in clinical trials and cut opioid use days roughly in half. The catch is timing: you need to be fully detoxed before starting, because naltrexone will trigger severe withdrawal if any opioids are still in your system. Only about 42% of people who haven’t already detoxed successfully start naltrexone, compared to 100% for buprenorphine or methadone. It works well for people who have already cleared the withdrawal phase and want a safety net against relapse.
How Tapering Works
If you’re currently taking prescription opioids and want to stop, tapering is the standard medical approach. The goal is to reduce your dose gradually enough that withdrawal stays manageable. Most commonly, this means reducing your dose by 5% to 20% every four weeks. A faster taper drops 10% to 20% per week, while a rapid taper (used in supervised settings) reduces 20% to 50% on the first day and then 10% to 20% daily.
Slower tapers are generally more comfortable and more successful. Pauses are built in if symptoms become too intense. Your body needs time to adjust at each new level before stepping down again, and pushing too fast is a common reason tapers fail. This isn’t something to attempt on your own. A prescriber can adjust the pace based on how you’re responding.
Therapy That Targets Relapse
Medication handles the physical side. Therapy handles the patterns, triggers, and thinking that drive relapse. Cognitive behavioral therapy has the strongest evidence for opioid use disorder, with research showing meaningful treatment effects specifically for opioid dependence.
The core of CBT for addiction is identifying the situations, people, places, and internal states that trigger the urge to use, then building concrete alternatives. If stress after work was a cue to use, therapy helps you recognize that pattern and rehearse a different response before you’re in the moment. If certain friends or locations are tied to use, the work involves restructuring your routines to reduce exposure to those triggers.
A major focus is dismantling the thought patterns that lead to relapse. Thoughts like “just this once won’t hurt” or “I’ve already failed, so why bother” are predictable cognitive distortions that show up in nearly everyone recovering from addiction. CBT treats these as testable beliefs rather than facts. Your therapist will help you examine the evidence: has “just once” ever actually stayed at once? Does one setback erase months of progress? Challenging these automatic thoughts with your own experience builds a more realistic internal narrative.
Skills training rounds out the approach, targeting the gaps that opioid use may have filled: managing emotions, solving problems, navigating conflict, and tolerating discomfort without numbing it. These are learnable skills, not personality traits, and they improve with practice.
Peer Support: Two Different Models
Support groups provide accountability and connection, but they aren’t all the same. The two most accessible options operate on different philosophies.
Narcotics Anonymous follows the 12-step model: spiritual in framework, peer-led exclusively by people in recovery, focused on abstinence, and built around long-term fellowship. It emphasizes helping others as a path to helping yourself, and groups are organized around specific substances. For many people, the structure, community, and sponsorship model provide a lifeline.
SMART Recovery uses cognitive behavioral and motivational principles in a group setting. Meetings are led by trained facilitators who may or may not be in recovery themselves. There’s no spiritual component. The focus is on self-empowerment and building relapse prevention skills, with the expectation that those skills can be learned within a few months. SMART welcomes any addiction type in the same group and allows members to set personalized goals, which can include abstinence or reduced use. It places less emphasis on long-term attendance or social network change, though shorter participation tends to produce less benefit.
Neither model is universally better. Some people attend both. The right fit depends on whether you respond more to community accountability and spiritual frameworks or to structured skills training and self-directed goals.
Keeping Naloxone Nearby
Relapse is a real possibility during recovery, and tolerance drops fast once you stop using. A dose that was routine before treatment can be fatal after even a short period of abstinence. Naloxone, the overdose-reversal nasal spray, should be in your home and with people close to you.
The signs of overdose are slow or absent breathing, extreme sleepiness, a slow heartbeat, pinpoint pupils, and not responding when spoken to or touched. To use the nasal spray: lay the person on their back, tilt their head back, insert the nozzle into one nostril, and press the plunger. Call emergency services immediately. If there’s no response after two to three minutes, give a second spray in the other nostril. Each device contains one dose and can’t be reused. Naloxone is available over the counter at most pharmacies and through many community health organizations at no cost.